Elly Ryu
Keine laufenden Positionen mehr
Vermögen: 17 128 $ am 31.03.2024
Profil
Elly Ryu formerly worked at Spectrum Pharmaceuticals, Inc., as Director-Accounting & Accounting from 2017 to 2019, Acrotech Biopharma LLC, as Director-Finance & Accounting in 2019, Sesen Bio, Inc., as Chief Accounting Officer & Controller from 2021 to 2023, and Skillz, Inc., as Chief Accounting Officer & Controller in 2023.
Ms. Ryu received her Masters Business Admin degree from the University of California, Irvine and undergraduate degree from Sogang University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2023 | 7 431 ( 0,02% ) | 16 868 $ | 31.03.2024 | |
SKILLZ INC. CLASS A
0,00% | 05.07.2023 | 40 ( 0,00% ) | 260 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Elly Ryu
| Unternehmen | Position | Ende |
|---|---|---|
| SKILLZ INC. | Comptroller/Controller/Auditor | 08.09.2023 |
| CARISMA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.03.2023 |
Acrotech Biopharma LLC
 Acrotech Biopharma LLC Pharmaceuticals: MajorHealth Technology Acrotech Biopharma LLC manufactures generic pharmaceuticals. The company is headquartered in United States. | Director of Finance/CFO | 01.11.2019 |
| SPECTRUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.03.2019 |
Ausbildung von Elly Ryu
| University of California, Irvine | Masters Business Admin |
| Sogang University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| SKILLZ INC. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Acrotech Biopharma LLC
Acrotech Biopharma LLC Pharmaceuticals: MajorHealth Technology Acrotech Biopharma LLC manufactures generic pharmaceuticals. The company is headquartered in United States. | Health Technology |
